• Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

cancer

  • Protein TRIM29 can serve as a new way of tracking certain skin cancers
    April 17, 2019

    Protein TRIM29 can serve as a new way of tracking certain skin cancers

    scientificinquirer
  • Epigenetic solutions may offer a different path for leukemia treatments
    April 16, 2019

    Epigenetic solutions may offer a different path for leukemia treatments

    scientificinquirer
  • Daily Dose: HPV vaccines effective preventing cervical cancer; MDMA continues to prove its worth
    April 5, 2019

    Daily Dose: HPV vaccines effective preventing cervical cancer; MDMA continues to prove its worth

    thebioscienceguy
  • Daily Dose: Monsanto earns its name; What does Elsevier do with all all that paywall money?
    March 29, 2019

    Daily Dose: Monsanto earns its name; What does Elsevier do with all all that paywall money?

    thebioscienceguy
  • SCINQ Daily Science Report: Half of the world’s child cancer cases go undiagnosed
    March 15, 2019

    SCINQ Daily Science Report: Half of the world’s child cancer cases go undiagnosed

    scientificinquirer
  • Defects in DNA repair can cause cancer but now there might be a solution
    February 25, 2019

    Defects in DNA repair can cause cancer but now there might be a solution

    scientificinquirer
  • Digging deep to figure out how CAR-T really works
    January 13, 2019

    Digging deep to figure out how CAR-T really works

    scientificinquirer
  • microRNAs may offer a resistance proof cancer therapy
    January 12, 2019

    microRNAs may offer a resistance proof cancer therapy

    scientificinquirer
  • Tall people more prone to cancer, evolutionary biologist
    January 9, 2019

    Tall people more prone to cancer, evolutionary biologist

    scientificinquirer
  • New breast cancer drug shows promise in large phase III clinical trial
    January 7, 2019

    New breast cancer drug shows promise in large phase III clinical trial

    scientificinquirer
Previous Page
1 … 44 45 46 47 48 … 53
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
 

Loading Comments...